Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Compass Therapeutics, Inc. | 90,000 | reported | 02 Jan 2026 | tx 7+564,066 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | Compass Therapeutics, Inc. | 90,000 | 0.00 USD | deriv |
| 11 Feb 2025 | GRANT_AWARD | Compass Therapeutics, Inc. | 40,000 | 0.00 USD | deriv |
| 09 Feb 2024 | GRANT_AWARD | Compass Therapeutics, Inc. | 40,000 | 0.00 USD | deriv |
| 08 Feb 2023 | GRANT_AWARD | Compass Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 18 Feb 2022 | GRANT_AWARD | Compass Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 19 Jun 2020 | PURCHASE | Compass Therapeutics, Inc. | 64,066 | 5.00 USD | |
| 19 Jun 2020 | PURCHASE | Compass Therapeutics, Inc. | 250,000 | 5.00 USD |